iHuman (IH)
NYSE:IH
US Market
Holding IH?
Track your performance easily

iHuman (IH) Financial Statements

73 Followers

iHuman Financial Overview

iHuman's market cap is currently ―. The company's EPS TTM is $0.334; its P/E ratio is 4.90; iHuman is scheduled to report earnings on December 5, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue-$ 251.53M$ 230.61M$ 242.68M-
Gross Profit-$ 177.10M$ 163.19M$ 169.88M-
EBIT-$ 38.54M$ 22.61M$ 11.29M-
EBITDA-$ 38.54M$ 22.61M$ 11.29M-
Net Income Common Stockholders-$ 39.48M$ 21.79M$ 13.12M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 152.24M$ 949.60M$ 856.33M$ 794.09M$ 134.22M
Total Assets$ 191.99M$ 1.22B$ 1.13B$ 1.09B$ 172.75M
Total Debt$ 1.31M$ 13.69M$ 18.10M$ 28.42M$ 5.37M
Net Debt$ -150.93M$ -935.92M$ -838.24M$ -765.66M$ -128.85M
Total Liabilities$ 81.77M$ 485.30M$ 460.77M$ 475.74M$ 77.28M
Stockholders Equity$ 111.56M$ 739.39M$ 668.59M$ 618.42M$ 95.47M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

iHuman Earnings and Revenue History

iHuman Debt to Assets

iHuman Cash Flow

iHuman Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis